Drugs for Insomnia and Improving Quality of Life (QOL): Research and Development of Ramelteon, an MT1/MT2 -Receptor Agonist

Folia Pharmacologica Japonica - Japan
doi 10.1254/fpj.131.16
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Japanese Pharmacological Society

Related search

Development and Evaluation of Oral Cancer Quality-Of-Life Questionnaire (QOL-OC)

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Differential Function of Melatonin MT1 and MT2 Receptors in REM and NREM Sleep

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Brain Injury Results in Lower Levels of Melatonin Receptors Subtypes MT1 and MT2

Neuroscience Letters
Neuroscience
2017English

Ramelteon and Improved Insomnia in Alcohol-Dependent Patients: A Case Series

Journal of Clinical Sleep Medicine
PulmonaryNeurologyRespiratory Medicine
2011English

Psychoactive Drugs and Quality of Life

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2003English

Development and Validation of the Positive Affect and Well-Being Scale for the Neurology Quality of Life (Neuro-Qol) Measurement System

Quality of Life Research
EnvironmentalPublic HealthOccupational Health
2013English

Overview of Research and Development for Anticancer Drugs

Journal of Cancer Therapy
2016English

Occupancy of Agonist Drugs at the 5-Ht1a Receptor

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2003English

Improving Productivity and the Quality of Work Life

Public Productivity Review
1980English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy